Maternal obesity is linked with adverse outcomes for mothers and babies. To get an overview of risks related to obesity in pregnant women, a systematic review of reviews was conducted. For inclusion, reviews had to compare pregnant women of healthy weight with women with obesity, and measure a health outcome for mother and/or baby. Authors conducted full-text screening, quality assurance using the AMSTAR tool, and data extraction steps in pairs. Narrative analysis of the 22 reviews included show gestational diabetes, pre-eclampsia, gestational hypertension, depression, instrumental and caesarean birth, and surgical site infection to be more likely to occur in pregnant women with obesity compared to women with a healthy weight. Maternal obesity is also linked to greater risk of preterm birth, large-for-gestational-age babies, fetal defects, congenital anomalies, and perinatal death. Furthermore breastfeeding initiation rates are lower and there is greater risk of early breastfeeding cessation in women with obesity compared with healthy weight women. These adverse outcomes may result in longer duration of hospital stay, with concomitant resource implications. It is crucial to reduce the burden of adverse maternal and fetal/child outcomes caused by maternal obesity.
Introduction
Maternal obesity is becoming an increasing public health issue, and it is known that nutrition and metabolism play a crucial role in the health and wellbeing of both mother and fetus (1). Maternal obesity is reaching epidemic proportions, particularly in the United States (US), where prevalence of obesity in women aged 20-39 years increased from 28.4% in 1999 to 34% in 2008 (2, 3) but has now fallen slightly to 31.9% (4). Across Europe, similar increases from lower starting levels are seen. The latest European Perinatal Health Report showed that the lowest levels of overweight or obesity in pregnant women were in Poland (25.6%), France (27.2%), and Slovenia Accordingly, our research group set out to conduct a systematic review of systematic reviews, as promoted by the Cochrane Collaboration (10) and described by other papers (11, 12). The aim was to summarise the findings of published systematic reviews regarding the possible risks for pregnant women with obesity, and their infants, compared to pregnant women with a healthy weight and their infants.
Methods

Search strategy
The accepted definitions of obesity (greater than or equal to Body Mass Index (BMI) 30 kg/m 2 ), severe obesity (BMI ≥ 35 kg/m 2 ), and healthy weight between 18.5 and 24.9 kg/m 2 (13) were planned for use. A protocol was developed a priori, outlining Search string: (Pregnancy OR "Postpartum Period" OR pregnant OR "post partum"
OR postpartum OR "post natal" OR postnatal OR puerperium OR antenatal OR prenatal OR gestation OR gestational OR gravida OR perinatal) AND (Obese OR obesity) AND ("Systematic review" OR "meta-analysis")
Our search was restricted to peer-reviewed articles and we included mainly systematic reviews of cohort studies or case studies, where outcomes were compared for women with obesity and women of healthy weight. We included systematic reviews of intervention/experimental studies if the control groups would provide outcomes due to obesity. All pregnant women were included, with no age, ethnicity or parity restriction, and no language restrictions were used. The outcomes measured had to be health outcomes (risks and complications) for the pregnancy, mother and/or baby. It was not possible to assess publication bias statistically, by funnel plot tests, as review analyses were mixed (e.g., narrative and meta-analyses).
Similarly, a meta-analysis was not possible due to heterogeneity between reviews (particularly in relation to differing definitions of obesity and severe obesity), and over-lapping of studies between most reviews, which would have led to doublecounting of data.
A total of 638 reviews was found (159 in PubMed, 50 in CINAHL, 37 in Cochrane
Definitions of obesity used in the reviews differed, possibly due to the change in the Institute of Medicine definition of the obese category from >29 to ≥30 in 2009. In addition, one review did not state the definition of obesity (39) , 7 reviews had included at least one study with an obesity definition down to BMI 25 kg/m², and 7
included at least one study using a definition of <29/30 kg/m², for their "normal BMI"
category (Table 1) . Authors' definitions are used throughout.
Reviews were conducted from 2007 to 2014, with included study publication dates ranging from 1969 to 2014. Most reviews involved studies from the United States (US) and United Kingdom (UK), with wide representation of papers from other countries across the world (Table 1) . Four reviews presented only a narrative synthesis of results (28, 33, 39, 40) and all others performed meta-analyses of crude or adjusted data.
The number of studies used in all reviews was 624, an average of 28 studies in each systematic review (range 3-70), most of which were case-control or cohort studies.
Of these, 51 were overlapping (included in more than one review), giving a total of 573 studies used. The objectives and scope of included reviews varied. Only one concerned general outcomes of maternal obesity; most studied specific fetal outcomes such as still-birth/death/miscarriage (n=4), and congenital disorders (n=3), maternal pregnancy disorders (n=5), and mode of birth (n=3).
Negative health outcomes of obesity in pregnant women
Gestational diabetes mellitus
The association between maternal obesity and gestational diabetes mellitus (GDM) was reported in two reviews (35, 27 ) published in 2007 and 2009, involving both lowand high-income countries (Table 1) . A total of 76 case-control or cohort studies were used after exclusion of over-lapping ones, published from 1992-2006/7. In one of the reviews (35) , the estimated risk of developing gestational diabetes was four times higher among women with obesity (unadjusted ratio: 3.05-4.21) and nine times respectively (29). The second review used narrative synthesis, and found that women with obesity were 3-10 times more likely to have pre-eclampsia compared with normal weight women, and 4.5-8.7 times more likely to develop gestational hypertension (40) . The authors believe many factors could cause this increased risk, such as insulin resistance, genetics, immunology, nutrition, and infective agents, as well as an unhealthy diet and lack of physical activity (40).
Since those reviews, a retrospective study of 120 million women admitted for birth in US hospitals showed an increase in pre-eclampsia rates over 30 years, with obesity listed as one cause for the increase (54). Two cohort studies in Canada (44) and Scotland (47) also observed a positive association between high BMI and gestational hypertension and pre-eclampsia, giving credence to our review's results. Table 2 ).
Mode of birth
The increase in CS and instrumental vaginal birth were suggested to be due to: a possible link between increased cholesterol deposits in the myometrium of women with obesity, affecting contractions (24); an increase in maternal soft tissue inside the pelvis narrowing the birth canal and increasing difficult births especially with a macrosomic infant, or a poorer response to oxytocin administration (37) .
Associations between obesity and increased rate of CS have been observed in several more recent studies, published after the latest review in 2009 (24). The studies span many different countries and all indicate the same increased rate of CS in women with obesity (43, 45, 47, 55, 56, 57, 58), reinforcing these results.
Surgical site infection
Two reviews were included (33, 39), with a total of 22 studies after over-lapping ones were removed, from 22 countries, published 1990-2012. Both reviews used narrative synthesis. One (39) found a significant association between obesity and surgical site infection (SSI) in two studies only, and four other studies did not find this association.
The second review (33) showed that 12 of the 13 studies supported a relationship between obesity and SSI ( Although the review did document the risk of having an extremely low birth weight baby (<1000g) for obese and very obese women separately (31), it was based on one study and so is not presented here. When authors accounted for publication bias, the apparent protective effect of obesity on low birth weight was no longer seen (31).
Since publication of those reviews, a study in Romania (n=500) found a higher incidence of intrauterine growth restriction in pregnancies of women with obesity (66). This unusual finding may be due to chance; a result of the small sample size, or perhaps due to co-morbidity of the mothers. Two large US studies, published since the two reviews (30, 31), found that pregnant women with obesity had reduced odds of having small for gestational age babies (67) or a greater prevalence for large-forgestational age babies (68). On balance, it would appear that the reviews' (30, 31, 38) conclusion that pre-pregnancy obesity decreases the risk of low birth weight (as all babies of women with obesity tend to be bigger than average) is most likely to be correct, but the effect may be small.
Fetal defects (malformation) and congenital anomalies Three reviews were included (25, 28, 42), involving at least 11 countries (one study mentioned Scandinavia but did not fully describe the countries). Fourteen crosssectional, case-control and cohort studies were used excluding ones over-lapping, or non-related to maternal obesity, all published 1969-2010 ( The four reviews agreed on many potential mechanisms for the results found. Two agree on the point that obesity during pregnancy itself increases the risk for maternal co-morbidities that are risk factors for stillbirth and miscarriage (21, 36). Another theory discussed in two reviews was the possibility that thinner women could have a better ability to feel a decrease in fetal movements, and would thus seek care as soon as movements declined (21, 36).
We found three studies published after those reviews. Two supported the relationship between maternal obesity and increased rates of neonatal/perinatal death (75, 45), and a large cohort study of singleton births (n=2,868,482) found rates of stillbirth increased with increasing BMI (76), thus confirming our review's results.
Miscellaneous outcomes
One moderate-quality review (38) , involving 49 studies from 15 countries, published 1990-2007 (Table 1) , found an increased risk of birth over 41 to 42 weeks gestation, increased rates of induction of labour, more frequent use of oxytocin augmentation and higher incidence of failure to progress in labour in women with obesity compared with those of healthy weight (38) . Also found was that babies of women with obesity needed neonatal intensive care more often, and had higher rates of fetal compromise and meconium stained liquor. Women with obesity compared with those of ideal weight had a higher risk of postpartum haemorrhage and a longer duration of hospital stay (2.84 days (95% CI 2.77-2.91) compared with 2.4 days for normal weight women) ( Table 2 ).
Longer duration of hospital stay in women with obesity has also been found in Scottish (47), and Australian (9) studies, which leads to higher healthcare costs (77). 
Breastfeeding
Two systematic reviews, of moderate quality, were included (32, 41), with 29 studies from nine different countries, when the 11 overlapping studies were removed. Cohort studies, surveys, reviews of medical records, and database studies were considered, all published 1989-2011 (Table 1) . Women with obesity were less likely to initiate breastfeeding than normal weight women, with ORs from 1.38-3.09 in one review (32) and 1.19-3.65 in the second (41) . Seven out of 15 studies in one review (32) found that women with obesity breastfed for a shorter duration than did women with normal weight, and the second found an increase in early cessation of breastfeeding, with a range of hazard ratios from 1.24-2.54 (41) ( Table 2 ).
The review authors suggest the reasons that women with obesity may have difficulty in breastfeeding may be physiological, behavioural, socio-cultural, psychological and medical (32, 41). For example, women with obesity may have elevated progesterone levels which may prevent the usual fall in progesterone following birth that leads to lactogenesis (32). Large breasts may also make latching on more difficult (32). There may also be complex socio-cultural reasons why women with obesity are less likely to breastfeed successfully, such as lower socio-economic group, not having been breastfed themselves, smoking, low self-esteem, poor mental health or solely that they may feel more uncomfortable breastfeeding in public (32).
Studies published after the most recent review (41) confirm that women with obesity had lower initiation rates and were at greater risk of stopping breastfeeding than women of normal weight (78, 79, 80, 81, 82, 83). One study found that women with high pre-pregnant BMI tend to breastfeed for shorter durations due to lack of comfort or confidence with their body image (79).
Discussion
This review of reviews has presented the health risks for women with obesity and their fetuses/babies. Risks include gestational diabetes (identified as a risk factor in one moderate and one high-quality review, based on 76 studies (27, 35)), gestational hypertension and pre-eclampsia (54 studies in one moderate and one high-quality review (40, 29)), and mental ill-health expressed as antenatal anxiety and depression, and postpartum depression (62 studies in one high-quality review (23)).
At birth, the odds for caesarean section were increased, ranging from 2-2.36 in three included reviews (37, 38, 24) , one of high quality and two of moderate, including 62
studies. An increase in instrumental birth was also noted (38) .
Surgical site infection was increased after CS (two reviews (33, 39) using narrative synthesis only and both of moderate quality, based on 22 studies). Breastfeeding was less likely to be initiated and/or maintained (two moderate-quality reviews (32, 41), based on 29 studies, with findings corroborated by recent research (78, 79)).
The health risks for babies of mothers with obesity include an increase in the risk of pre-term birth (<32, <33 and <37 weeks gestation) for all women with obesity, shown in the one moderate and two high-quality reviews identified (26, 31, 38), based on 133 studies. Also found was an increase in the risk of larger 'large for gestational age' babies (30, 38) and a decrease in the risk of low birth weight (30), in the one moderate and one high-quality review, covering 82 studies. Two reviews (25, 42), one moderate and one high-quality, based on 14 studies, found that obesity in mothers pre-and during pregnancy was a significant predictor of neurodevelopmental problems or malformations in the children ( A key cause for women with obesity having higher rates of GDM is that they tend to have a less healthy diet and take less physical activity. As authors of two reviews also believe that hyperglycaemia, undiagnosed diabetes (25) or nutritional deficiencies (25, 42) may be causative factors for fetal malformation, increased promotion of taking folic acid, a healthy diet and sufficient exercise for all women planning pregnancy should be instigated, as a matter of policy. Women should also be supported, through national subsidised programmes, to lose weight before they conceive and to control their weight in pregnancy. Research into this area of care is currently scant (84, 85) and indicates that weight advice is seldom provided (86) .
Despite this, there are some promising intervention findings regarding women's improvements in healthy eating and physical activity (87, 88) . Interventions targeting pregnant women with obesity should take into consideration the potential poor mental health of these women, who may have disordered eating and thus need extra support (89) . In relation to breastfeeding, clinicians do not appear to provide extra support (90) to women with obesity, nor do they always seek help (78), so health care professionals need to identify women who may struggle breastfeeding, and provide extra assistance.
Comprehensive, updated systematic reviews on gestational diabetes in women with obesity, the risk of CSs and instrumental births to women with obesity, and the risk of pre-term birth should now be repeated, as the latest studies in reviews considered here were published in 2006-8. A revised systematic review on pre-eclampsia in women with obesity, including the results of three large recent studies (44, 47, 54), would also be useful. Although two narrative reviews presented here showed that surgical site infection was increased in women with obesity (33, 39), five studies in those reviews showed no association, and more recent studies have been conducted (59, 60) . There is, therefore, a need for a new systematic review on SSI in relation to obesity in pregnancy, including a meta-analysis, if possible.
Further research is needed into the causes and management of depression in pregnant and postpartum women with obesity, particularly as there may be a reverse causal pathway, where women with poor mental health have difficulty with weight management (23). More research is also needed on specific interventions targeting the reduction of gestational diabetes in women with obesity, and into how race, ethnicity and parity may influence rates of pre-term birth.
As many of the studies included in the reviews on breast-feeding did not control for confounding variables (32), further research is needed. More qualitative studies are also recommended regarding these women's perspective in order to understand their infant feeding decisions and behaviour (41, 32) . Recent trials of interventions such as peer counselling or extra support targeted at women with overweight or obesity (91, 92) did not find it improved breastfeeding rates or continuation of breastfeeding.
However, as a Cochrane systematic review has shown that such support given to women irrespective of weight status is effective (93), further research is needed to develop feasible and acceptable interventions for women with obesity.
Review strengths and limitations
To our knowledge, this is the first review of reviews summarising the risks associated with maternal obesity. The key strength is the amount and quality of literature from all languages that has been gathered together, summarised and discussed critically, including reference to recent trial results. The result is a succinct, exhaustive and extensive review that includes both mother and baby outcomes, and physical and mental health. The inability to perform a meta-analysis is a limitation, but was not possible due to heterogeneity between reviews (particularly in relation to differing definitions of obesity and severe obesity), and over-lapping of studies between most reviews, which would have led to double-counting of data. We have limited the outcomes to maternal obesity compared to normal weight pregnant women without reference to women who are overweight, as some studies included in the reviews had 'overweight' categories that overlapped with normal or obese definitions. We have not used grey literature, but think it unlikely that there are unpublished systematic reviews in this area. Importantly, we focused on maternal obesity, but excessive gestational weight gain may also be an issue, that can exacerbate some of these health risks.
Conclusions and recommendations
The negative impact of obesity before and during pregnancy on mothers' and their babies' health is clear. Health conditions such as gestational diabetes, pre-eclampsia and gestational hypertension are common in pregnant women with obesity. There is also an increased rate of instrumental and caesarean section births, and a greater rate of surgical site infections and antenatal and postnatal depression. The risk of large for gestational age babies is higher, and lower breastfeeding initiation rates and shorter breastfeeding duration are also seen. In addition, obesity is linked to a greater risk of pre-term birth, fetal defects, congenital anomalies, and perinatal death. These adverse outcomes lead to increased costs, due to longer duration of hospital stay and higher treatment costs. Investing in national subsidised programmes aimed at supporting women to lose weight before they conceive, and control their weight in pregnancy, may thus confer long-term health and monetary benefits.
Research that is needed in this area, in addition to updates systematic reviews, includes: qualitative studies on women's perspectives of breastfeeding, in order to understand their infant feeding decisions and behaviour, and explorations of why pregnant women with obesity suffer from poorer mental health compared to those of healthy weight. Research into effective pre-conception interventions to help women with obesity lose weight before they conceive, and between pregnancies, is also essential, in order to reduce the burden of maternal and fetal outcomes caused by maternal obesity. Insulin receptors and post-receptor defects associated with obesity may be further exacerbated by pregnancy. A systemic inflammation seems to be involved as indicated by higher levels of serum C-reactive protein, interleukin-6 and ferritin. As adipocytes secrete pro-inflammatory cytokines, inflammation is usually associated with obesity. Therefore, the abundance of adipocytes in obese women could produce excess inflammatory markers that in turn would lead to the development of GDM.
Obesity is a possibly modifiable risk factor, so obese women should be informed about their risks and supported to lose weight prior to conception.
Pre-eclampsia and hypertension Salihu, 2012
Narrative synthesis: BMI ≥ 30 were 3-10 times more likely to have preeclampsia BMI ≥ 30 were 4.5-8.7 times more likely to develop gestational hypertension Insulin resistance, genetics, immunology, nutrition, and infective agents may cause pre-eclampsia, as may failure of the trophoblast cells to invade the myometrium, oxidative stress, endothelial dysfunction, calciotrophic hormone dysfunction, release of growth factors, antiagiogenic proteins.
More research on causative factors and development of effective preventive interventions.
Wang, 2013
Pre-eclampsia, pooled OR: BMI ≥ 30, 2.68 (2.40-3.00) BMI ≥ 35, 3.43 (2.59-4.55) Autonomic function, hyperactivity of the sympathetic nervous system may influence blood pressure directly, alterations in metabolic functions, including insulin resistance, diabetes, dyslipidemia and increased blood pressure, oxidative stress and chronic inflammation, which can increase the risk of pre-eclampsia.
Further research to determine efficacy of antenatal diet or lifestyle interventions to prevent preeclampsia and identify the best choice for women with high BMI. Further research on restricted weight gain during pregnancy.
Mode of birth
Surgical site infection (SSI) Anderson, 2013
Synthesis of integrative review: 12 out of 13 studies supported a relationship between obesity and SSI Obesity can result in serious post-operative complications for child bearing women undergoing caesarean section such as SSI.
Community midwives could implement wound assessments post-discharge, when SSI is often detected.
Lakhan, 2010
Narrative synthesis Overall SSI, OR: BMI ≥ 30, 2.13 (1.08-4.18) and 2.0 (1.3-3.0) in two studies, four studies showed no association.
The lack of consistency in the risk factors studied may have influenced the risk factors found to be independently associated with SSI.
Future research to test a CSspecific risk index for surveillance purposes, ultimately enhancing quality of care for women undergoing CS. Weight stigmatization, physical ill health, low socioeconomic status, and poor diet may contribute to effect on mental disorders. Gestational diabetes or backache in pregnancy may also increase the association. Also, women with a history of depression may gain weight before pregnancy, due to the obesogenic effect of many antipsychotics or antidepressants, or to over-eating.
Further research on risk of gestational diabetes and preeclampsia, on behavioral change interventions for pregnant or postpartum women the effect of obesity on women's health behaviors and change in their behaviour. The presence of confounding variables related to obesity and preterm birth might explain some of the results. Studies in this review tried to modify this effect by exclusion, matching, using multiple regression to control for some variables, or by comparing some variables between the two groups (obesity and normal weight). The presence of confounding variables related to obesity and low birth weight might explain some of the results. Studies in this review tried to modify this effect (see above). When authors accounted for publication bias, b y addition of nine imputed studies, the apparent protective effect of obesity on low birth weight was no longer seen.
Pre-term birth
Health personnel need to be aware that obesity in women is not necessarily protective against having LBW.
Yu, 2013
LBW (<2,500 g), OR: Pre-pregnancy BMI ≥ 30, 0.81 (0.80-0.83)
LGA (above the 90th percentile) , OR: Pre-pregnancy BMI ≥ 30, 2.08 (1.95-2.23) HBW (>4,000 g), OR:
Nutrition in the mother can change the structure, physiology, and metabolism in the fetus, predisposing that child for high BMI in adulthood. Malnutrition or over-nutrition during pregnancy may cause epigenetic changes in the fetus/baby, which Recognition of the association between obesity and birthweight has implications for education of mothers to reduce pre-pregnancy BMI. Seven out of 15 studies found that women with obesity breastfed for a shorter duration than did women with normal weight Obesity is associated with delayed lactogenesis. As this review also showed that women with obesity intend to breastfeed for shorter durations than other women, perhaps part of the delay in time to first feed and tendency to give up before hospital discharge is behavioural rather than physiological.
Qualitative studies from women's perspective as well as quantitative studies are necessary, to explore the relationship between maternal obesity and breastfeeding.
Turcksin, 2012
Women with BMI ≥ 30, compared with normal weight women Initiation of breastfeeding, range of ORs (10 studies): 1.19 to 3.65 Low milk transfer at 60 hrs, range of ORs: 6.14 (1.10-37.41) Early cessation of breastfeeding, range of hazard ratios:1.24 to 2.54
Maternal obesity is associated with a decreased intention and initiation of breastfeeding, a shortened duration of breastfeeding, a less adequate milk supply and a delayed onset of lactogenesis. Larger breasts can be a mechanical barrier to put the baby to the breast, and can therefore have a negative influence on the milk production and secretion.
Additional education for health care professionals. Breastfeeding promotion interventions and counselling practices targeting women with BMI ≥ 30, and assistance for breastfeeding, starting before conception until 6 months post-partum.
CS= caesarean section, SSI=surgical site infection, PTB=preterm birth, LBW=low birth weight, HBW=high birth weight, LGA=large for gestational age, OR=odds ratio (95% confidence interval), RR=relative risk, HR=hazard ratio, FA = folic acid, NTD = neural tube defect
